ProTip Closes $4.7M Financing

ProTip SA, a Strasbourg, France-based emerging medical device company, has raised $4.7m in Series C financing (approximately €3.8m).

The round was led by new investor Seventure, with participation from existing investors Fonds Lorrain des Materiaux (FLM), the Berchet family-office, Alsace Amorcage and other private investors.

The company intends to use the funding to complete the first human clinical trial of its ENTegral (TM) device, a permanent implant to replace the larynx in patients who have undergone a total laryngectomy, as well as launch wider trials with the aim of bringing the implant to market.

Founded in 2004 and led by Maurice Berenger, CEO, ProTip is dedicated to the development of innovative solutions for patients suffering from larynx malfunctions. Its priority focus is to develop a permanent implant for laryngectomized patients.



Join the discussion